Abstract We extensively analyzed genomic DNA and messenger RNA (mRNA) from 62 unrelated Korean patients with familial adenomatous polyposis (FAP) for identification of germline adenomatous polyposis coli (APC) gene mutations. We adopted both single-strand conformation polymorphism (SSCP) analysis and a method of analysis involving the reverse transcription-polymerase chain reaction (RT-PCR) followed by a protein truncation test (PTT). DNA sequencing confirmed all alterations represented by aberrant bands. Germline mutations were identified in 38 patients (61%). Nineteen of the detected mutations were presumed to be novel, thus emphasizing the heterogeneity of the mutational spectrum in Korean FAP patients. In the initial 48 patients, SSCP analysis was followed by PTT for those patients for whom no detectable mutations were found by SSCP. Using this combined approach, we identified germline APC gene mutations in 29 of the 48 FAP patients (60%), including 6 patients in whom SSCP analysis failed to distinguish the mutant allele. In the 14 later patients, we identified truncating mutations in 9 patients (64%) using PTT only. Our results confirm that the mutation detection rate with PTT was superior to that with SSCP, and suggest that PTT would be a more practical screening method to detect germline mutations of the APC gene in FAP patients.
Introduction
Familial adenomatous polyposis (FAP) is an autosomal dominantly inherited disease with almost complete penetrance. It is characterized by the development of hundreds to thousands of adenomatous polyps throughout the colon. Some of these polyps inevitably progress to colorectal carcinoma if prophylactic colectomy is not performed. In addition to colonic polyposis, FAP patients have a variable prevalence of extracolonic manifestations of both a benign and a malignant nature. Thus, FAP is considered a generalized growth disorder.
Traditional surveillance strategies for at-risk members of FAP families have depended on frequent endoscopic examinations, beginning at puberty. However, identification of the adenomatous polyposis coli (APC) gene responsible for FAP allowed the carrier status of family members to be determined (Groden et al. 1991; Kinzler et al. 1991; Nishisho et al. 1991) . Thus, genetic testing for APC gene mutations in FAP patients and their family members is now regarded as an important part of management in FAP.
Since the identification of the APC gene, many different germline mutations have been reported. To date, germline mutations of the APC gene have been documented in about 500 FAP patients (Beroud and Soussi 1996; Gayther et al. 1994; Wallis et al. 1994; Dobbie et al. 1996; van der Luijt et al. 1997) . The majority of germline mutations (over 95%) identified cause truncation of the APC protein.
With growing data on APC mutations and findings of biological significance in APC protein domains, the variations in FAP manifestations have been partly explained. Although many studies have shown both inter-and intrafamilial phenotypic variations among patients carrying the identical mutation Paul et al. 1993; Varesco et al. 1993; Giardiello et al. 1994; van der Luijt et al. 1995; Scott et al. 1995) , some studies have indicated clear genotype-phenotype correlations between the location of the APC gene mutation and the characteristic manifestations of FAP. These include the number of polyps Spirio et al. 1993; Gayther et al. 1994; Scott et al. Germline mutations of the APC gene in Korean familial adenomatous polyposis patients Friedl et al. 1996) , the age of onset and death Caspari et al. 1994; Gayther et al. 1994; Scott et al. 1995; Friedl et al. 1996) , the presence of congenital hypertrophy of the retinal pigment epithelium (CHRPE) Caspari et al. 1995) , and the occurrence of desmoid tumors (Caspari et al. 1995; Davies et al. 1995; Scott et al. 1995; Dobbie et al. 1996; Eccles et al. 1996) . Thus, the evidence strongly suggests that there are different functional mutations within the APC gene with respect to the position of the mutation.
Among the many techniques developed for the identification of diverse mutations in genetic disease, single-strand conformation polymorphism (SSCP) analysis has been widely employed for its simplicity (Orita et al. 1989 ). However, the large size of the APC coding region makes the detection of mutations labor-intensive and costly. The observation that the majority of mutations in the APC gene resulted in a truncated protein led to the development of a test based on the in-vitro translation, coupled with the transcription of polymerase chain reaction (PCR) products for selectively detecting translation-terminating mutations (Powell et al. 1993; van der Luijt et al. 1994) . The protein truncation test (PTT) has a great advantage in that after only five separate PCR amplifications, the entire coding region of the APC gene is sufficiently covered.
To characterize germline mutations of the APC gene in 62 unrelated Korean FAP patients, we screened the entire coding region of the APC gene by SSCP analysis and PTT.
In this study, we demonstrated the superiority of PTT in the detection of germline mutations in FAP patients. We also present the genotype-phenotype correlations detected in our patients.
Patients and methods
Patients and extraction of DNA and RNA Blood samples and clinical information about 62 unrelated Korean FAP patients were obtained via the Korean Polyposis Registry, established in 1990. All 62 patients gave their informed consent prior to blood collection. Genomic DNA was extracted from the leukocytes of these patients by a salting-out procedure. Total cellular RNA isolation was performed in 20-ml aliquots of fresh peripheral blood samples, using a commercially available RNA/DNA/protein isolation reagent (Tri Reagent, Molecular Research Center, Cincinnati, OH, USA).
PCR and single-strand conformation polymorphism (SSCP) Oligonucleotide primers were designed to amplify the entire coding region of the APC gene. Primer sets used to amplify APC exons 1-14 and the 17 overlapping segments of exon 15 have been described . DNA samples were amplified for SSCP analysis using PCR under the following conditions: 5 min at 95°C; 1min at 95°C, 1 min at 54°C, and 1 min at 72°C for 35 cycles; and 5min at 72°C. Reaction mixtures, in a total volume of 25 µl, contained the following: 50 ng of DNA template, 0.4 µM each primer, 120 µM each dNTP, PCR buffer (10mM Tris, 50 mM KCl, 1.5 mM MgCl2, 0.001% gelatin; Perkin Elmer Cetus, Foster City, CA, USA) 0.1 µCi/µl 32P dCTP (3000 Ci/mmol) (Amersham, Flylesbury, U.K.), and Taq DNA polymerase 0.01 U/µl (Perkin Elmer Cetus). After amplification, 15 µl of reaction mixture was diluted with of 15 µl of formamide dye (deionized formamide 95%, 10 mM ethylenediaminetetraacetate [EDTA], 0.05% xylene cyanol, and 0.05% bromphenolblue). Samples were denatured at 95°C for 4 min and placed on ice prior to being loaded into SSCP gel. For the optimum resolution in SSCP gel, large PCR products (more than 350 bp) were digested with appropriate restriction enzymes. Four µl of each reaction mixture was loaded into a 6% (48 : 1 acrylamide: bis) non-denaturing polyacrylamide gel. Electrophoresis was performed at 400 V constant voltage at 4°C for 13-16 h, or at 800 V constant voltage at room temperature for 2.5-3 h. Gels were blotted onto Whatman 3 MM paper (Maidstone, U.K.), covered with vinyl wrap, and then dried. Dried gels were exposed to Fuji RX film (Fuji Photo Film, Tokyo, Japan) or Kodak X-OMAT AR film (Eastman Kodak, Rochester, NY, USA) for 12-24 h.
Protein truncation test (PTT) and reverse transcription PCR (RT-PCR)
The full length of the APC gene was analyzed for mutations, using PTT as described previously (Powell et al. 1993; Roest et al. 1993; van der Luijt et al. 1994) . The entire coding region of the APC gene was amplified in five overlapping segments by PCR, using primers described previously (Powell et al. 1993; van der Luijt et al. 1994) . Briefly, to investigate for mutations in exons 1-14, DNA fragments were amplified from complementary DNA templates prepared by reverse transcription (GIBCO/BRL SuperScript II RT; Grand Island, NY, USA) of messenger RNA (mRNA). Exon 15, which covers 77% of the entire coding region, was amplified directly from genomic DNA. The primers used for PCR amplification were designed to be preceded by a T7 promoter sequence and Kozak sequence for the initiation of transcription and translation (5ЈGGATCCTAATACGACTCACTATAGGGACCATG3Ј). A 25-µl reaction mixture, containing 5 µl of the PCR product, 1 µl of 35 S-methionine (1000 Ci/mmol; Amersham, Arlington Heights, IL, USA), 0.5 µl RNAsin (recombinant 40 U/µl), 1µl TnT T7 RNA polymerase, 0.5 µl amino acid methionine (Ϫ) mix, and 10 µl TnT wheat germ extract (Promega, Madison, WI, USA), was incubated at 30°C for 1 h. This product (10 µl) was electrophoresed on a 4%-20% sodium dodecyl sulfate (SDS)-polyacrylamide Ready Gel (Novex, San Diego, CA, USA) for 2 h at 150 V, fixed, dried, and autoradiographed for 12-24 h, using Kodak X-Omat AR film.
Sequencing analysis
Sequencing templates were produced by PCR for samples showing aberrant mobility on SSCP or PTT. All PCR products for sequencing analysis were purified using a Qiaquick PCR purification column (Qiagen, Valencia, CA, USA) and directly sequenced using a dye terminator cycle sequencing kit and an automatic fluorescent sequencer (ABI 377; Applied BioSystems, Foster City, CA, USA) according to the manufacturer's instructions. For RT-PCR products, internal oligonucleotides were designed (sequences available on request). Sequencing reactions were carried out on both sense and antisense strands.
Results and discussion
Germline mutations of the APC gene were identified in 38 (61%) of the 62 Korean FAP patients. Twenty of the mutations were small deletions; 11 were point mutations resulting in stop codons; 4 were 1-to 4-base-pair insertions; 2 were sequence alterations in mRNA, and 1 was a base substitution in the splicing recognition site. Nineteen of the detected mutations were presumed to be novel.
Initially, in 48 FAP patients, we used SSCP analysis to screen for mutations as SSCP has been used widely to screen for mutations in the APC gene. Using this approach, we identified causative mutations (mutations resulting in truncation of the APC protein) in 23 patients (48%) (Fig. 1) .
Because the frequency of mutations detected with SSCP was lower than expected , and because of the observation that most of the germline APC gene mutations identified in FAP patients resulted in truncation of the APC protein, the protein truncation test (PTT) was used for 25 patients whose mutations were not identified by SSCP. Using PTT, we were able to identify mutations in an additional 6 patients. Thus, the combined use of SSCP and PTT allowed the detection of germline APC gene mutations in 29 of the 48 (60%) FAP patients.
In 14 newer patients, we used only PTT to screen for mutations (Fig. 1) . In this group, we identified truncating mutations in 9 patients (64%). Thus, our results indicate that the mutation detection rate with PTT was superior to that with SSCP. Our overall mutation detection rate (61%) is comparable with that in a previous report . Table 1 shows a summary of all germline mutations and the available information on the clinical manifestations in the index case in each family (the patients in our study). All the identified mutations in the open reading frame resulted in truncations of the APC protein. Seventy-four % of the mutations were located in the 5Ј half of exon 15. The two most common mutations seen were a 5-base pair (bp) deletion at codon 1309, in six patients (SNU-F1, F34, F42, F43, MJH-F1, and NMC-F1), and a 5-bp deletion at codon 1061 in three patients (SNU-F10, F46, and CMC-F18), which together accounted for 24% of the detected mutations. In During this study, we also found a series of polymorphisms. Three of the polymorphisms (TAC to TAT at codon 486, GCA to GCG at codon 545, and TCG to TCT at codon 1756) had been previously reported . Additionally, one rare polymorphism was found at the 3Ј border of intron 13, 9-13 nucleotides from the 5Ј end of exon 14 (AGAAA to TGTTT). The allelic frequency of that polymorphism was Ͼ0.12 in the 49 healthy unrelated persons.
In six patients (SNU-F29, CCU-F1, CNU-F4, KNH-F2, PNU-F6, and PNU-F11), the results of SSCP analysis were normal, but germline mutations were discovered by PTT. Contrary to the nucleotide deletions or insertions easily detected by SSCP, the mutations identified in these patients were single nucleotide substitutions. This finding indicates that PTT can identify additional mutations missed by SSCP alone.
In screening for mutations of the APC gene, many techniques, such as SSCP analysis (Groden et al. 1991) , denaturing gradient gel electrophoresis (DGGE) (Fodde et al. 1992) , and ribonuclease protection assay (RPA) , have been employed. SSCP and DGGE have been preferentially used for their simplicity. However, they are time-consuming methods for the analysis of huge genes such as APC because they are capable of screening only small pieces of DNA, due to the limitation of DNA-size resolution on gel (Sheffield et al. 1993) . Also, as the size of the DNA increases, generally the sensitivity falls. The optimal size of DNA fragments for sensitive base substitution detection by SSCP is 200 bp. Therefore, the failure of SSCP to detect some mutations could be due to inherent defects in SSCP or possibly, could result from poor gel running conditions. Consequently, SSCP is not a convenient method for the analysis of mutations in large, multi-exonic genes such as APC.
Our results indicate that it would be more practical to employ PTT alone for rapid and accurate screening for APC gene mutations in FAP patients. Since 76% of the detected mutations in our series were located between codons 699 and 1370, and 67% of the reported mutations are located between codons 680 and 1700, it would be logical to perform PTT of this region first, using two PTT sets covering codons 680-1700.
The two most common mutations we observed were a 5-base pair (bp) deletion at codon 1309 in six patients and a 5-bp deletion at codon 1061 in three patients, which together accounted for 24% of the detected mutations. These two codons have been reported to be the most frequent sites of mutation (15%-26%) by others (Cottrell et al. 1992; Nagase et al. 1992; Miyoshi et al. 1992; Ando et al. 1993; The exon boundary is indicated by the slashed line. This mutation leads to a frameshift and a stop codon 8 bp downstream in the new reading frame b The mutation was not identified by single-strand conformation polymorphism analysis, but the abnormal protein was observed in the PTT c Exon skipping (exons 7, 8, and 9) was identified by the PTT and direct sequencing of the cDNA. In this patient, exon 6 was directly connected to exon 10, which leads to a frame shift d The same mutations have previously been reported in the literature Varesco et al. 1993; Caspari et al. 1994; van der Luijt et al. 1997) . In 24 patients (39%), our approach did not reveal the underlying genetic defect. This presents a major problem for the presymptomatic diagnosis of FAP by mutation analysis. The most likely explanations for the failure to identify mutations in these patients include promoter or enhancer site mutations, gross structural rearrangements, or the existence of another candidate gene for FAP (Kraus et al. 1994; McPherson et al. 1994; van der Luijt et al. 1997) .
APC gene mutations at different positions have been reported to account for some of the differences in the phenotypic manifestations of FAP (Gayther et al. 1994; Wallis et al. 1994; Caspari et al. 1995; Dobbie et al. 1996) . Patients with mutations between codons 1444 and 1578 were almost invariably found to develop desmoid tumors (Caspari et al. 1995) . In our series, however, there was no patient with a mutation in this region of the APC gene, and four patients who developed desmoid tumors had mutations outside this region.
It has also been reported that a germline mutation in codon 1309 of the APC gene leads to the development of colonic polyps at a younger age, giving rise to early-onset colorectal cancer Caspari et al. 1994; Gayther et al. 1994 ). In our series, the mean age at the time of diagnosis of FAP was 29 years in the six patients with mutations in codon 1309, somewhat younger than the mean age of 36 years in patients whose mutations were located elsewhere in the APC gene.
Mutations at the 5Ј end of APC are associated with relatively few colonic polyps, usually fewer than 100, and with a later onset of symptoms, but still a significant risk of colon cancer ). This condition is referred to as attenuated adenomatous polyposis coli (AAPC). Our patient KNH-F2 had the greatest 5Ј end mutation, a splice acceptor site mutation at exon 5, which is beyond the functional boundary of AAPC at codon 168 .
Congenital hypertrophy of the retinal pigment epithelium (CHRPE), a retinal lesion frequently associated with FAP, is associated with mutations located between codons 457 and 1445 of the APC gene (Wallis et al. 1994; Caspari et al. 1995) . In eight patients who had CHRPE in our series, all the identified mutations were located within this boundary.
Identification of the APC mutations responsible for FAP in our series of families should have a great impact on management. The other family members at risk can be easily diagnosed within 1 or 2 days (Park et al. 1994 ). Subsequently, family members can be divided into those carrying the mutated APC genes (who can benefit from appropriate management to prevent colorectal cancer) and those without the mutations (who can be relieved of the anxiety of developing the disease).
Our results in this study confirmed that the PTT was superior to SSCP for the detection of germline mutations of the APC gene responsible for FAP. The employment of PTT would facilitate the detection of germline mutations of the APC gene and aid in the management of families affected with FAP.
